Heidelberg Pharma AG (LTS:0QW5) Change In Inventory: €-2.10 Mil (TTM As of May. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0QW5 Heidelberg Pharma AG LTS:0QW5
46 GF Score
Price €2.57
GF Value €3.14
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Heidelberg Pharma AG Change In Inventory?

Heidelberg Pharma AG LTS:0QW5 46 Change In Inventory is €-2.10 Mil as of May. 2026. GuruFocus rates LTS:0QW5 with a GF Score™ of 46/100 and a GF Value™ of €3.14 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Heidelberg Pharma AG's change in inventory for the quarter that ended in May. 2026 was €-0.77 Mil. It means Heidelberg Pharma AG's inventory increased by €0.77 Mil from Feb. 2026 to May. 2026 .

Heidelberg Pharma AG's change in inventory for the fiscal year that ended in Nov. 2025 was €-3.29 Mil. It means Heidelberg Pharma AG's inventory increased by €3.29 Mil from Nov. 2024 to Nov. 2025 .

Heidelberg Pharma AG's Total Inventories for the quarter that ended in May. 2026 was €10.41 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Heidelberg Pharma AG's Days Inventory for the quarter that ended in May. 2026 was 2,407.56.

Inventory Turnover measures how fast the company turns over its inventory within a year. Heidelberg Pharma AG's Inventory Turnover for the quarter that ended in May. 2026 was 0.04.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Heidelberg Pharma AG's Inventory-to-Revenue for the quarter that ended in May. 2026 was 2.31.

Heidelberg Pharma AG  (LTS:0QW5) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Heidelberg Pharma AG's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=10.026/0.38*365 / 4
=2,407.56

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Heidelberg Pharma AG's Inventory Turnover for the quarter that ended in May. 2026 is calculated as

Inventory Turnover=Cost of Goods Sold / Average Total Inventories
=0.38 / 10.026
=0.04

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Heidelberg Pharma AG's Inventory to Revenue for the quarter that ended in May. 2026 is calculated as

Inventory-to-Revenue=Average Total Inventories / Revenue
=10.026 / 4.345
=2.31

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Heidelberg Pharma AG Change In Inventory Related Terms

Heidelberg Pharma AG Change In Inventory Historical Data

* Premium members only.

The historical data trend for Heidelberg Pharma AG's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Heidelberg Pharma AG Change In Inventory Chart

Heidelberg Pharma AG Annual Data
Trend Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23 Nov24 Nov25
Change In Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.52 -3.84 -5.90 -1.33 -3.29

Heidelberg Pharma AG Quarterly Data
Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26 May26
Change In Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.36 -3.33 1.03 0.97 -0.77
LTS:0QW5
46GF Score
Heidelberg Pharma AG LTS:0QW5
Change In Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Heidelberg Pharma AG Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in May. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-2.10 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Inventory →
What does a Change In Inventory of €-2.10 Mil mean?
Heidelberg Pharma AG (LTS:0QW5) has a Change In Inventory of €-2.10 Mil as of May. 2026. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Heidelberg Pharma AG and its competitors.
Is Heidelberg Pharma AG's Change In Inventory too high?
Heidelberg Pharma AG's current Change In Inventory is €-2.10 Mil. Overall, Heidelberg Pharma AG has a GF Score™ of 46/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Heidelberg Pharma AG's Change In Inventory compare to VRTX and REGN?
Heidelberg Pharma AG's Change In Inventory of €-2.10 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Biotechnology company?
A good Change In Inventory depends on the Biotechnology industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Heidelberg Pharma AG and its competitors. Heidelberg Pharma AG's current Change In Inventory is €-2.10 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Heidelberg Pharma AG stock overvalued right now?
Based on GuruFocus' analysis, Heidelberg Pharma AG (LTS:0QW5) is currently considered Modestly Undervalued. The stock's GF Value™ is €3.14, compared to a current price of €2.57 — trading 18.2% below its estimated fair value. The current Change In Inventory is €-2.10 Mil. Heidelberg Pharma AG's overall GF Score™ is 46/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For Heidelberg Pharma AG (LTS:0QW5), the current Change In Inventory is €-2.10 Mil as of May. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Heidelberg Pharma AG (LTS:0QW5) Overvalued in 2026?

Based on GuruFocus' analysis, Heidelberg Pharma AG stock appears to be undervalued. The current stock price of €2.57 is trading 18.2% below its estimated GF Value™ of €3.14. GuruFocus considers Heidelberg Pharma AG to be Modestly Undervalued.

Key valuation signals for LTS:0QW5:

  • Change In Inventory: €-2.10 Mil
  • GF Value™: €3.14 vs. price of €2.57 (18.2% below fair value)
  • GF Score™: 46/100 with 5 warning signs

No single metric tells the full story. See the LTS:0QW5 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Heidelberg Pharma AG Business Description

Other Exchanges HPHA:GermanyHPHA:Austria
Address Gregor-Mendel-Street 22, Ladenburg, DEU, 68526
Heidelberg Pharma AG is a biopharmaceutical company developing oncology treatments through antibody drug conjugates (ADCs), which combine antibody specificity with toxin potency to selectively target and kill cancer cells. The Company researches, develops, and produces these ADCs, and has built an ADC toolbox using various antibodies and payloads to address multiple cancers and overcome tumor resistance. Its activities focus on its proprietary ATAC technology based on Amanitin, the toxin of the death cap mushroom, leveraging its biological mechanism as a novel cancer therapy. The ATAC platform is used to develop proprietary ADC candidates and is also applied in collaborations with third parties.
46GF Score

Get the complete analysis for LTS:0QW5

Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.57
Price
€3.14
GF Value